Naoki Ogane
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
- Oncology 10
- Drug Transport and Resistance Mechanisms 4
- Cancer-related Molecular Pathways 3
- Cancer Cells and Metastasis 2
-
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- Masanori Yasuda (21 shared papers)Masaki Miyazawa (10 shared papers)Mitsutake Yano (8 shared papers)Yoichi Kameda (10 shared papers)Shingo Kamoshida (10 shared papers)Hisashi Narahara (4 shared papers)Kosei Hasegawa (5 shared papers)R. Yoshiyuki Osamura (7 shared papers)
In The Last Decade
Naoki Ogane
26 papers receiving 428 citations
Peers
Comparison fields: 5 of 57
- Reproductive Medicine 104
- Cancer Research 160
- Obstetrics and Gynecology 72
- Pathology and Forensic Medicine 79
- Oncology 116
Countries citing papers authored by Naoki Ogane
This map shows the geographic impact of Naoki Ogane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Ogane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Ogane more than expected).
Fields of papers citing papers by Naoki Ogane
This network shows the impact of papers produced by Naoki Ogane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Ogane. The network helps show where Naoki Ogane may publish in the future.
Co-authors
The 25 scholars most cited alongside Naoki Ogane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 69 | |
| 2 | 2019 | 41 | |
| 3 | 2018 | 39 | |
| 4 | 2005 | 27 | |
| 5 | 2010 | 25 | |
| 6 | 2010 | 25 | |
| 7 | 2019 | 25 | |
| 8 | 2012 | 22 | |
| 9 | 2014 | 21 | |
| 10 | 2008 | 19 | |
| 11 | 2013 | 16 | |
| 12 | 2013 | 15 | |
| 13 | 2020 | 13 | |
| 14 | 2016 | 13 | |
| 15 | 2021 | 12 | |
| 16 | Organic cation transporter 2 for predicting cisplatin-based neoadjuvant chemotherapy response in gastric cancer. | 2015 | 12 |
| 17 | 2000 | 10 | |
| 18 | 2018 | 8 | |
| 19 | 2005 | 6 | |
| 20 | 2015 | 5 |
About Naoki Ogane
Naoki Ogane is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Reproductive Medicine, having authored 26 papers that have together received 437 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer Mechanisms and Therapy (3 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Reproductive Medicine (104 citations), Cancer Research (160 citations), Obstetrics and Gynecology (72 citations), Pathology and Forensic Medicine (79 citations) and Oncology (116 citations). Naoki Ogane has collaborated with scholars based in Japan and Australia. Frequent co-authors include Masanori Yasuda, Masaki Miyazawa, Mitsutake Yano, Yoichi Kameda, Shingo Kamoshida, Hisashi Narahara, Kosei Hasegawa, R. Yoshiyuki Osamura, Takeshi Hirasawa and Hiroshi Kajiwara. Their work appears in journals such as Oncology Reports, Anticancer Research, Modern Pathology, Scientific Reports and Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.